• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

电抽搐治疗抵抗性抑郁症。

Electroconvulsive therapy in treatment resistant depression.

机构信息

Department of Psychiatry, Washington University in St Louis School of Medicine, St Louis, MO, USA; Department of Psychiatry, University of Texas Rio Grande Valley School of Medicine, Harlingen, TX, USA.

Department of Psychiatry, Washington University in St Louis School of Medicine, St Louis, MO, USA; Department of Psychiatry, University of Texas Rio Grande Valley School of Medicine, Harlingen, TX, USA.

出版信息

J Neurol Sci. 2022 Mar 15;434:120095. doi: 10.1016/j.jns.2021.120095. Epub 2021 Dec 18.

DOI:10.1016/j.jns.2021.120095
PMID:34979372
Abstract

Electroconvulsive therapy (ECT) is a treatment modality for patients with treatment resistant depression (TRD), defined as failure of two adequate antidepressant medication trials. We provide a qualitative review of ECT's effectiveness for TRD, methods to optimize ECT parameters to improve remission rates and side effect profiles, and ECT's proposed neurobiological mechanisms. Right unilateral (RUL) electrode placement has been shown to be as effective for major depression as bilateral ECT, and RUL is associated with fewer cognitive side effects. There is mixed evidence on how to utilize ECT to sustain remission (i.e., continuation ECT, psychotropic medications alone, or a combination of ECT and psychotropic medications). Related to neurobiological mechanisms, an increase in gray matter volume in the hippocampus-amygdala complex is reported post-ECT. High connectivity between the subgenual anterior cingulate and the middle temporal gyrus before ECT is associated with better treatment response. Rodent models have implicated changes in neurotransmitters including glutamate, GABA, serotonin, and dopamine in ECT's efficacy; however, findings in humans are limited. Altogether, while ECT remains a highly effective therapy, the neurobiological underpinnings associated with improvement of depression remain uncertain.

摘要

电抽搐治疗(ECT)是一种治疗难治性抑郁症(TRD)的方法,定义为两种充分的抗抑郁药物试验失败。我们提供了对 ECT 治疗 TRD 的有效性、优化 ECT 参数以提高缓解率和副作用特征的方法以及 ECT 提出的神经生物学机制的定性综述。与双侧 ECT 相比,右侧单侧(RUL)电极放置已被证明对重度抑郁症同样有效,并且 RUL 与较少的认知副作用相关。关于如何利用 ECT 维持缓解(即继续 ECT、单独使用精神药物或 ECT 和精神药物联合使用)存在混合证据。与神经生物学机制有关,据报道,ECT 后海马-杏仁核复合体的灰质体积增加。ECT 前扣带回下前部和中颞叶之间的高连通性与更好的治疗反应相关。啮齿动物模型表明,包括谷氨酸、GABA、血清素和多巴胺在内的神经递质的变化与 ECT 的疗效有关;然而,在人类中的发现是有限的。总的来说,虽然 ECT 仍然是一种非常有效的治疗方法,但与抑郁症改善相关的神经生物学基础仍不确定。

相似文献

1
Electroconvulsive therapy in treatment resistant depression.电抽搐治疗抵抗性抑郁症。
J Neurol Sci. 2022 Mar 15;434:120095. doi: 10.1016/j.jns.2021.120095. Epub 2021 Dec 18.
2
Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): study protocol for a randomized non-inferiority trial of magnetic seizure therapy versus electroconvulsive therapy.磁惊厥治疗抑郁症的确证疗效和安全性试验(CREST-MST):磁惊厥治疗与电惊厥治疗比较的随机非劣效性试验研究方案。
Trials. 2021 Nov 8;22(1):786. doi: 10.1186/s13063-021-05730-7.
3
Brain Volumetric Correlates of Right Unilateral Versus Bitemporal Electroconvulsive Therapy for Treatment-Resistant Depression.右单侧与双颞叶电抽搐治疗难治性抑郁症的脑容积相关性。
J Neuropsychiatry Clin Neurosci. 2019 Spring;31(2):152-158. doi: 10.1176/appi.neuropsych.18080177. Epub 2018 Nov 21.
4
The impact of treatment resistance on outcome and course of electroconvulsive therapy in major depressive disorder.治疗抵抗对重度抑郁症患者电休克治疗结局及病程的影响
Acta Psychiatr Scand. 2023 Jun;147(6):570-580. doi: 10.1111/acps.13550. Epub 2023 Apr 5.
5
Grey Matter changes in treatment-resistant depression during electroconvulsive therapy.电抽搐治疗治疗抵抗性抑郁症中的灰质变化。
J Affect Disord. 2019 Nov 1;258:42-49. doi: 10.1016/j.jad.2019.07.075. Epub 2019 Jul 31.
6
ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol.电休克疗法(ECT)与氯胺酮治疗难治性抑郁症的疗效对比:ELEKT - D研究方案
Contemp Clin Trials. 2019 Feb;77:19-26. doi: 10.1016/j.cct.2018.12.009. Epub 2018 Dec 17.
7
Cognitive-behavioral therapy as continuation treatment to sustain response after electroconvulsive therapy in depression: a randomized controlled trial.认知行为疗法作为电抽搐治疗后维持抑郁缓解的延续治疗:一项随机对照试验。
Biol Psychiatry. 2014 Aug 1;76(3):194-202. doi: 10.1016/j.biopsych.2013.11.030. Epub 2013 Dec 12.
8
Health-related quality of life in a clinical trial of ECT followed by continuation pharmacotherapy: effects immediately after ECT and at 24 weeks.一项关于电休克治疗后继续药物治疗的临床试验中的健康相关生活质量:电休克治疗后立即和 24 周时的效果。
J ECT. 2011 Jun;27(2):97-102. doi: 10.1097/YCT.0b013e318205c7d7.
9
Antidepressant Effects of Electroconvulsive Therapy Unrelated to the Brain's Functional Network Connectivity alterations at an Individual Level.电休克治疗的抗抑郁作用与个体水平上大脑功能网络连接性的改变无关。
Chin Med J (Engl). 2017 Feb 20;130(4):414-419. doi: 10.4103/0366-6999.199845.
10
Nonconvulsive Electrotherapy for Treatment Resistant Unipolar and Bipolar Major Depressive Disorder: A Proof-of-concept Trial.非惊厥电疗治疗耐药性单相和双相重性抑郁障碍:概念验证试验。
Brain Stimul. 2015 Sep-Oct;8(5):855-61. doi: 10.1016/j.brs.2015.06.011. Epub 2015 Jun 26.

引用本文的文献

1
AdipoRon as a Novel Therapeutic Agent for Depression: A Comprehensive Review of Preclinical Evidence.脂联素受体激动剂AdipoRon作为抑郁症的新型治疗药物:临床前证据的综合综述
Biomedicines. 2025 Jul 31;13(8):1867. doi: 10.3390/biomedicines13081867.
2
Comparative efficacy and safety of intravenous racemic ketamine, repetitive transcranial magnetic stimulation and electroconvulsive therapy for Stage 2 or higher treatment-resistant depression: A systematic review and network meta-analysis.静脉注射消旋氯胺酮、重复经颅磁刺激和电休克治疗对2期或更高程度难治性抑郁症的疗效和安全性比较:一项系统评价和网状荟萃分析。
PCN Rep. 2025 Jun 29;4(3):e70136. doi: 10.1002/pcn5.70136. eCollection 2025 Sep.
3
Repetitive Transcranial Magnetic Stimulation as Maintenance Treatment of Depression: The MAINT-R Randomized Clinical Trial.
重复经颅磁刺激作为抑郁症的维持治疗:MAINT-R随机临床试验
JAMA Netw Open. 2025 Jun 2;8(6):e2515881. doi: 10.1001/jamanetworkopen.2025.15881.
4
Neuropharmacology of Ketamine and Its Use in the Treatment of Major Depressive Disorder: A Review.氯胺酮的神经药理学及其在重度抑郁症治疗中的应用:综述
Cureus. 2025 Apr 30;17(4):e83244. doi: 10.7759/cureus.83244. eCollection 2025 Apr.
5
Effects of light therapy on amygdala connectivity and serotoninergic system in young adults with subthreshold depression.光疗法对阈下抑郁年轻成年人杏仁核连接性和血清素能系统的影响。
Dialogues Clin Neurosci. 2025 Dec;27(1):184-200. doi: 10.1080/19585969.2025.2503367. Epub 2025 Jun 1.
6
Luteolin and its antidepressant properties: From mechanism of action to potential therapeutic application.木犀草素及其抗抑郁特性:从作用机制到潜在治疗应用
J Pharm Anal. 2025 Apr;15(4):101097. doi: 10.1016/j.jpha.2024.101097. Epub 2024 Sep 7.
7
Investigating the impact of electroconvulsive therapy on brain networks and sleep: an observational study protocol.探究电休克治疗对脑网络和睡眠的影响:一项观察性研究方案。
BMJ Open. 2025 Mar 7;15(3):e098859. doi: 10.1136/bmjopen-2025-098859.
8
Wearables as Translational Physiomarkers and Clinical Endpoints in Insomnia Research: Can Sleep Research Advance Psychiatry?可穿戴设备作为失眠研究中的转化生理标志物和临床终点:睡眠研究能否推动精神病学发展?
J Sleep Res. 2025 Oct;34(5):e70028. doi: 10.1111/jsr.70028. Epub 2025 Feb 28.
9
Therapeutic Approaches to Tackle the Challenge of Depression That Is Resistant to Treatment-A Narrative Review.应对难治性抑郁症挑战的治疗方法——一项叙述性综述
Health Sci Rep. 2025 Jan 22;8(1):e70370. doi: 10.1002/hsr2.70370. eCollection 2025 Jan.
10
Enhanced behavioral impact of optimized bupropion-encapsulated bilosomes over traditional niosomes treating depression.优化后的安非他酮包封双分子层脂质体相较于传统非离子表面活性剂囊泡治疗抑郁症时具有更强的行为学影响。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):4373-4392. doi: 10.1007/s00210-024-03549-y. Epub 2024 Oct 30.